L T Dooley

Efficacy and safety of infliximab monotherapy for plaque-type psoriasis: a randomised trial

Umesh Chaudhari, Pat Romano, LD Mulcahy et al. · The Lancet · 2001 · 904 citations

Medicine, Pharmacology, Pharmacotherapy +11

Infliximab improves signs and symptoms of psoriatic arthritis: results of the IMPACT 2 trial

Christian Antoni, Gerald G. Krueger, Kurt de Vlam et al. · Annals of the Rheumatic Diseases · 2005 · 716 citations · Full text

Medicine, Clinical Sciences, Pharmacotherapy +15

Infliximab maintains a high degree of clinical response in patients with active psoriatic arthritis through 1 year of treatment: results from the IMPACT 2 trial

Arthur Kavanaugh, Gerald G. Krueger, Anna Beutler et al. · Annals of the Rheumatic Diseases · 2006 · 202 citations · Full text

Medicine, Clinical Sciences, Pharmacotherapy +16

Infliximab treatment results in significant improvement in the quality of life of patients with severe psoriasis: a double-blind placebo-controlled trial

Steven R. Feldman, Kenneth B. Gordon, M Bala et al. · British Journal of Dermatology · 2005 · 132 citations

Medicine, Pharmacology, Pharmacotherapy +13